STAT+: How a four-month FDA delay forced a small biotech company to close its doors
Stat News • 4/6/2026
Summary
A small biotech company reached a breakthrough with the FDA in February by agreeing to a clinical trial plan. However, the agreement came four months too late, leading the company to close its doors.
Advertisement
Lindy Score Breakdown (V4.2)
4h
Age
1
Sources
from cluster
3
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 2 days ago
STAT+: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
Stat News • Today
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 2 days ago
Opinion: When my child is in psychosis, the pediatric health care system can’t help us
Stat News • Today
Opinion: ‘Medical nutrition’ helps keep my son, and many others, healthy. But insurance won’t cover it
Stat News • Today
What the peptide craze reveals about Americans’ relationship with risk
Stat News • Today